Amit Sachdev, EVP and Chief Patient and External Affairs Officer at Vertex Pharmaceuticals ($VRTX), sold about $28.4 million in company shares across nine open market transactions over the past year. His most recent sale occurred on February 25, 2026. These sales rank him 497th among 11,678 insiders by total value sold, exceeding the average of $8.6 million per insider and 6.4 transactions. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | F | Common Stock | 1518 | $485.11 | 67,599.0000 | 258,000,000 | 2.20% | 0.00% |
| Feb. 25, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | Common Stock | 1846 | $486.35 | 65,753.0000 | 258,000,000 | 2.73% | 0.00% |
| Feb. 19, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | M | Stock Option (Right to Buy) | 23479 | $0.00 | 0.0000 | 258,000,000 | 100.00% | 0.01% |
| Feb. 19, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | Common Stock | 4237 | $471.43 | 69,117.0000 | 258,000,000 | 5.78% | 0.00% |
| Feb. 19, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | Common Stock | 11712 | $470.54 | 73,354.0000 | 258,000,000 | 13.77% | 0.00% |
| Feb. 19, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | Common Stock | 7241 | $469.61 | 85,066.0000 | 258,000,000 | 7.84% | 0.00% |
| Feb. 19, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | Common Stock | 19662 | $468.57 | 92,307.0000 | 258,000,000 | 17.56% | 0.01% |
| Feb. 19, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | Common Stock | 10263 | $467.75 | 111,969.0000 | 258,000,000 | 8.40% | 0.00% |
| Feb. 19, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | Common Stock | 1848 | $465.80 | 122,232.0000 | 258,000,000 | 1.49% | 0.00% |
| Feb. 19, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | Common Stock | 2730 | $465.05 | 124,080.0000 | 258,000,000 | 2.15% | 0.00% |
| Feb. 19, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | Common Stock | 920 | $463.91 | 126,810.0000 | 258,000,000 | 0.72% | 0.00% |
| Feb. 19, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | M | Common Stock | 23479 | $155.57 | 102,704.0000 | 258,000,000 | 29.64% | 0.01% |
| Feb. 19, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | M | Common Stock | 25026 | $187.53 | 127,730.0000 | 258,000,000 | 24.37% | 0.01% |
| Feb. 19, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | M | Stock Option (Right to Buy) | 25026 | $0.00 | 0.0000 | 258,000,000 | 100.00% | 0.01% |
| Feb. 17, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | F | Common Stock | 2140 | $483.75 | 79,225.0000 | 258,000,000 | 2.63% | 0.00% |
| Feb. 17, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | A | Common Stock | 5789 | $0.00 | 81,365.0000 | 258,000,000 | 7.66% | 0.00% |
| Feb. 13, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | F | Common Stock | 3548 | $487.76 | 75,576.0000 | 258,000,000 | 4.48% | 0.00% |
| Feb. 10, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | F | Common Stock | 2057 | $468.41 | 79,124.0000 | 258,000,000 | 2.53% | 0.00% |
| Jan. 22, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | A | Common Stock | 7866 | $0.00 | 77,298.0000 | 258,000,000 | 11.33% | 0.00% |
| Jan. 22, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | A | Common Stock | 3883 | $0.00 | 81,181.0000 | 258,000,000 | 5.02% | 0.00% |
| Feb. 26, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | F | Common Stock | 3703 | $479.61 | 69,372.0000 | 257,899,999 | 5.07% | 0.00% |
| Feb. 24, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | F | Common Stock | 2470 | $483.28 | 73,075.0000 | 257,899,999 | 3.27% | 0.00% |
| Feb. 14, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | F | Common Stock | 2139 | $463.46 | 75,545.0000 | 257,899,999 | 2.75% | 0.00% |
| Feb. 12, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | A | Common Stock | 6211 | $0.00 | 77,684.0000 | 257,899,999 | 8.69% | 0.00% |
| Feb. 10, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | F | Common Stock | 2056 | $467.98 | 71,473.0000 | 257,899,999 | 2.80% | 0.00% |
| Feb. 4, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | A | Common Stock | 8210 | $0.00 | 66,415.0000 | 257,899,999 | 14.11% | 0.00% |
| Feb. 4, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | A | Common Stock | 7114 | $0.00 | 73,529.0000 | 257,899,999 | 10.71% | 0.00% |
| June 5, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | G | Common Stock | 4600 | $0.00 | 58,172.0000 | 260,500,000 | 7.33% | 0.00% |
| May 15, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | Common Stock | 32 | $430.93 | 62,772.0000 | 260,500,000 | 0.05% | 0.00% |
| Feb. 26, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | Common Stock | 3004 | $425.70 | 62,772.0000 | 260,500,000 | 4.57% | 0.00% |
| Feb. 23, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | F | Common Stock | 2469 | $431.79 | 65,776.0000 | 260,500,000 | 3.62% | 0.00% |
| Feb. 21, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | Common Stock | 3191 | $421.77 | 68,245.0000 | 260,500,000 | 4.47% | 0.00% |
| Feb. 16, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | F | Common Stock | 3498 | $424.01 | 78,313.0000 | 260,500,000 | 4.28% | 0.00% |
| Feb. 20, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | F | Common Stock | 2623 | $420.58 | 75,690.0000 | 260,500,000 | 3.35% | 0.00% |
| Feb. 20, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | Common Stock | 4254 | $420.79 | 71,436.0000 | 260,500,000 | 5.62% | 0.00% |
| Feb. 9, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | F | Common Stock | 2022 | $422.74 | 85,033.0000 | 260,500,000 | 2.32% | 0.00% |
| Feb. 12, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | Common Stock | 3222 | $420.24 | 81,811.0000 | 260,500,000 | 3.79% | 0.00% |
| Feb. 6, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | A | Common Stock | 5814 | $0.00 | 72,075.0000 | 260,500,000 | 8.77% | 0.00% |
| Feb. 6, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | A | Common Stock | 7866 | $0.00 | 79,941.0000 | 260,500,000 | 10.91% | 0.00% |
| Feb. 7, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Sachdev Amit | EVP Chief Patient & Ext Af Off | A | Common Stock | 7114 | $0.00 | 87,055.0000 | 260,500,000 | 8.90% | 0.00% |